Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Elvira Valera, Michael Mante, Scott Anderson, et al.
Journal of Neuroinflammation (2015) Vol. 12, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong, Dimitri Krainc
Nature Medicine (2017) Vol. 23, Iss. 2, pp. 1-13
Open Access | Times Cited: 733
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Chao Gao, Jingwen Jiang, Yuyan Tan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 418
Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review
Martina Rekatsina, Antonella Paladini, Alba Piroli, et al.
Advances in Therapy (2019) Vol. 37, Iss. 1, pp. 113-139
Open Access | Times Cited: 184
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
Sara A. Ferreira, Marina Romero‐Ramos
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 174
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Yunna Li, Yun Xia, Sijia Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 115
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Changyoun Kim, Edward Rockenstein, Brian Spencer, et al.
Cell Reports (2015) Vol. 13, Iss. 4, pp. 771-782
Open Access | Times Cited: 126
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T. Scerba, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 113
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Erskine Chu, Richelle Mychasiuk, Margaret L. Hibbs, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 86
Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
Elodie Kip, Louise C. Parr‐Brownlie
Ageing Research Reviews (2022) Vol. 78, pp. 101618-101618
Open Access | Times Cited: 53
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 45
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 22
Blood Biomarkers With Parkinson's Disease Clusters and Prognosis: The Oxford Discovery Cohort
Michael Lawton, Fahd Baig, Greg Toulson, et al.
Movement Disorders (2019) Vol. 35, Iss. 2, pp. 279-287
Open Access | Times Cited: 73
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Luca Soraci, Maria Elsa Gambuzza, Leonardo Biscetti, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1346-1360
Open Access | Times Cited: 30
Combination therapies: The next logical Step for the treatment of synucleinopathies?
Elvira Valera, Eliezer Masliah
Movement Disorders (2015) Vol. 31, Iss. 2, pp. 225-234
Open Access | Times Cited: 56
Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies
Neelima Gupta, Sukanya Shyamasundar, Radhika Patnala, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 9, pp. 765-781
Closed Access | Times Cited: 55
Therapeutic approaches in Parkinson's disease and related disorders
Elvira Valera, Eliezer Masliah
Journal of Neurochemistry (2016) Vol. 139, Iss. S1, pp. 346-352
Open Access | Times Cited: 51
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 315-330
Closed Access | Times Cited: 15
A case for seeking sex-specific treatments in Alzheimer’s disease
Marina A. Lynch
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Samo Ribarič
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4358-4358
Open Access | Times Cited: 5
Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy
Elvira Valera, Brian Spencer, Jerel Adam Fields, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 44
Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2018) Vol. 13, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 44
The neuropathology of multiple system atrophy and its therapeutic implications
Elvira Valera, Eliezer Masliah
Autonomic Neuroscience (2017) Vol. 211, pp. 1-6
Open Access | Times Cited: 43
Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice
Roland Rabl, C. Breitschaedel, Stefanie Flunkert, et al.
BMC Neuroscience (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top